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Abstract
Using probes recognizing variable regions (Vet) and joining
regions (Jy) of the T cell receptor (TCR) -y gene, we have
analyzed the usage of V-y genes in 24 patients with T cell acute
lymphoblastic leukemia (ALL) and 36 patients with B-precur-
sor ALL. In CD3- T-ALL derived from immature T cells, V-y
genes more proximal to Jy were frequently rearranged; Vy8,
V'y9, Vy10, and Vy1 1 were used in 19 of 24 rearrangements.
In contrast, CD3YT-ALL derived from a more mature stage of
T cell ontogeny, showed a high frequency of rearrangements
involving V-y genes distal to Jy; V'y2, Vy3, V'y4, and Vy5 were
used in 17 of 25 rearrangements. In B-precursor ALL, no nota-
ble bias of Vy gene usage was observed. This probably reflects
the possibility that TCRgenes may not rearrange according to
a T cell hierarchy when under control of a B cell gene program.
Furthermore, deletions of those Vy genes located 3' to rear-
ranged Vy genes were observed in all patients analyzed. This
supports the theory that loop deletion is a major mechanism
for TCR--y gene rearrangement.
Introduction
In addition to the T cell receptor (TCR)'a and : genes, a third
gene, y, has been shown to undergo somatic rearrangement in
T cells (1, 2). Similar to other rearranging genes, the TCR-y
gene is composed of variable (V), joining (J), and constant (C)
regions (2, 3). The number of Vy genes is much smaller than
observed with other rearranging genes; to date 14 Vy genes,
including 6 pseudogenes have been identified upstream to Jy
and &y (4). These Vy genes are divided into four families
(V'y, V-yII, VyIII, and VyIV) (4) and are shared by two sets of
Jy and Cy genes that show a strong homology to each other (2,
3, 5).
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The protein product of the TCR-y gene has been shown to
form a T cell receptor in association with the CD3 molecules
on the cell surface and may be involved in some types of
natural killer function (6-9). Although the specific roles of this
TCR and the T cell subset expressing this receptor are still
obscure, in general the TCR-y gene along with the other puta-
tive TCRgenes probably encode a diverse set of receptor pro-
teins involved in antigen recognition (8, 9).
In previous studies, we and others demonstrated a high
incidence of TCR-y gene rearrangement not only in T cell
acute lymphoblastic leukemia (T-ALL) but also in B-precursor
ALL (10-12). In this study we have used probes recognizing
Vy and Jy, and have analyzed the usage of Vy genes in 24
T-ALL and 36 B-precursor ALL. Vy genes more proximal to
Py were frequently used in T-ALL derived from immature
cells. In contrast, T-ALL derived from more mature T lineage
cells demonstrated a high frequency of rearrangements in-
volving Vy genes more distal to Jy and the most upstream
(distal) functional Vy gene showed the highest frequency of
rearrangement. In B-precursor ALL, no particular clustering
was observed. This observation may suggest that TCR-y gene
rearrangement in B-precursor ALL is adventitious and does
not follow the hierarchy observed in T lineage cells. Further-
more, deletions of Vy genes located downstream to rearranged
V~y genes were observed in all patients analyzed, indicating
loop deletion (13, 14) as the main mechanism for TCR-y gene
rearrangement.
Methods
Cell samples. Mononuclear cells were obtained from bone marrow by
Ficoll-Hypaque gradient centrifugation at the time of diagnosis and
before initiation of treatment. The samples evaluated contained > 90%
malignant cells. Reactivity of malignant cells with a panel of MAbwas
assessed by indirect immunofluorescence (15). The diagnosis of
T-ALL was based on the expression of the T cell-associated antigens
CD1, CD2, CD3, CD4, CD5, CD7, and CD8. T-ALL were divided into
two subgroups according to CD3expression (Table I). The diagnosis of
B-precursor ALL was based on the expression of the B-cell-associated
antigens CD19 and/or CD20 and the lack of surface Ig and T cell and
myeloid-associated antigens. The B-precursor ALL studied here fell
into two subgroups (16) (Table II): group III, Ia', CD19', and CDI0+;
and group IV, Ia', CDl9', CD10, and CD20'.
Southern blot analysis. High molecular weight DNAwas extracted
by standard procedures from the mononuclear cells and the DNA
samples were digested with restriction endonucleases. The digested
DNAwas subjected to electrophoresis in agarose gels and transferred
to nylon membranes. DNAsamples bound to membranes were then
hybridized to probes labeled with 32P by the random primer method
(17). Membranes were hybridized sequentially after removal of hybrid-
ized probes. Complete removal was confirmed by a test exposure be-
fore the next hybridization.
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Figure 1. (Top) Diagram of Vy region. E denotes Eco RI restriction
sites. (Bottom) Restriction mapof Jy and C'y region and the Jy
probe used in this study. B, E, and H denote BamHI, Eco RI, and
Hind III restriction sites, respectively. H* indicates a polymorphic
Hind III restriction site.
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Gene probes. A restriction map of the TCRy region is presented in
Fig. I and was derived from data presented in references 3, 4, and 18.
The Jy probe used in this study was an 0.7-kb Eco RI-Hind III genomic
fragment provided by Dr. T. H. Rabbitts (2). The JPy probe hybridized
to Jy 1.3 and Jy2.3 but not to Jy 1l.1, Jy 1.2, and Jy2. I (Fig. 1) ( 18). The
V-y probes used in this study, provided by Dr. T. W. Mak, were as
follows: VyI (360-bp Eco RI-Ava II fragment of cDNAHGPO3[19]),
V'yII (290-bp Eco RI-Acc I fragment of cDNA HGPO2(19); VyIII
(90-bp Eco RI-Apa I fragment of cDNAHGPO6[19]). The V'yI and
VyII probes contained complete sequences of the VyI and V'yII genes,
respectively. The V'yIII probe contained only that portion 3' to the Eco
RI site located in the VyIII gene. The VyI probe hybridized to all V'YI
family members (OVy 1, Vy2, Vy3, Vy4, Vy5, IV-y5, IVy6, 'Vy7,
and Vy8) and detected eight bands in Eco RI digests of germline DNA
(4). Designations for each band are shown in Fig. 6. The VyI probe
detected a single germline band after Barn HI digestion indicating that
all VyI genes lie within a single BamHI fragment. After hybridization
with the V'yII probe, Bam HI, Eco RI, and Hind III digests yielded
single germline bands. Of these, Eco RI and Hind III bands contained
only V-y9. The VyIII probe detected single germline bands after Bam
HI, Eco RI, and Hind III digestion. Hind III bands contained only
V'y 1O, but BamHI and Eco RI bands contained both V-y9 and Vy 10,
and VylIO and V-y I1, respectively. The order of genomic Vy genes is
shown in Fig. 1 (4, 20, 21). Rearrangements to Vy 11 may represent
rearrangements of 'V'yB (4) since they localize to the same Eco RI
fragment. Based on the sizes of the rearranged fragments, no rearrange-
ments of PV-yB were found.
Results
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Figure 2. Representative rearrangement patterns of the VY genes.
The patient numbers are noted above each lane. Lane G represents
the germline DNAcontrol. The germline position and size of the in-
dividual bands recognized are indicated by bars at the side of each
panel. (A and B) BamHI and Eco RI digests, respectively, probed
with the VyI probe. Cis a Hind III digest probed with the VyII
probe. D shows a Hind III digest probed with the VYII1 probe. Spe-
cific rearranged bands are indicated by *.
Analysis of TCR-,y gene rearrangement. Fig. 2 demonstrates
how the various Vy rearrangements are recognized. In Fig. 2
A, members of the Vy family are recognized using BamHI
and the VyI probe. Rearrangements of the V2, V3, and IV7
genes are recognized using this enzyme. Fig. 2 B shows that
rearrangements of the V4, V5, and V8 genes are recognized
using Eco RI and the VyI probe. Fig. 2 Cdemonstrates detec-
tion of rearrangement of Vy9, the only member described for
the VyII family using Hind III and the VyII probe. Finally,
Fig. 2 D uses Hind III and the VyIII probe to recognize rear-
rangement of Vy 1O, the only member as yet described for the
VyIII family.
Fig. 3 demonstrates recognition of rearranged Jy genes
using the Jy probe and the three restriction enzymes. As de-
scribed by Forster et al. (4), those Vy genes rearranged to Jy 1.3
or Jy2.3 in a particular cell were assigned based on sizes of
rearranged Jy bands after separate digestion with three en-
zymes (Bam HI, Eco RI, and Hind III) and using a Jy probe.
WhenVy genes were rearranged to Jy genes other than Jy 1.3
or Jy2.3, the usage of Jy and Vy genes was estimated by
hybridization patterns obtained using specific Vy probes. For
each representative patient, rearranged Jy bands are indicated
by a line and the particular Vy gene that has rearranged to that
Jy is given next to that line. Results presented in Figs. 2 and 3,
in conjunction with numerous other experiments, confirm the
published results (4) that Vy and Jy rearrangements are com-
paratively limited in number and can be assigned on the basis
of size. The data also indicate that of six pseudo Vy genes,
'Vy7 seems most capable of being rearranged in T cell or
B-precursor acute lymphoblastic leukemia. Results described
in this paper used these procedures to investigate Vy and Jy
gene rearrangement in acute lymphoblastic leukemia. In pre-
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Figure 3. Representative
36 rearrangement patterns of
J' genes. Patient num-
bers are noted above each
lane. Lane Gshows the
germline control, and the
V3 germline position and es-
timated size are indicated
at the left of each panel.
Specific rearranged bands
for each patient are indi-
cated by a small bar lead-
ing to the particular VT
gene which the size of the
band suggests has rear-
ranged in that patient as
noted by Forster et al.
(4). (A, B, and C) show
DNAcut with BamHI,
Hind III, and Eco RI, re-
spectively. All were
probed with the J-y probe.
vious reports (10, 11) we demonstrated rearrangements of
TCRy in 24 of 24 T-ALL and 36 of 57 B-precursor ALL. In
this study, we have analyzed Vy and Jy usage in these same
patients. Results of these studies are summarized in Table I for
T-ALL and Table II for B-precursor ALL. Data from the indi-
vidual blots are shown only to make specific points.
All T-ALL and 16 B-precursor ALL had biallelic rear-
rangements and 20 B-precursor ALL had single allelic rear-
rangements of the TCR-,y gene. In 22 T-ALL, germline bands
corresponding to 'y 1 and y2 loci were not detected after Bam
HI, Eco RI, or Hind III digestion indicating rearrangements to
Jy2.3 on both alleles (Table I). In contrast, the majority of
B-precursor ALL (14 of 16 patients) with biallelic rearrange-
ments retained y2 in germline configuration. Both y 1 and y2
germline bands were deleted in only 2 B-precursor ALL (Table
II). Therefore, it seems that most rearrangements in B-precur-
sor ALL occurred in the y 1 locus.
Usage of Vy genes in CD3- T-ALL. The usage of individ-
ual Vy genes in T-ALL is summarized in Table I and Fig. 4. 12
patients were examined and these contained a total of 24 rear-
rangements. In CD3- T-ALL, 19 of 24 rearrangements of the
Vy genes were located proximal to Jy. The usage of Vy8 was
most frequent; 9 of 24 rearrangements showed involvement of
V~y8. Vy9, belonging to the VyII family, was also frequently
used; Vy9 was rearranged on five alleles. Rearrangements of
Vy 10 (VyIII) and Vy 11 (VyIV) were observed on two and
three alleles, respectively. In contrast, involvement of V'yI
genes located in an upstream region were less frequent; V'y2
and Vy4 rearranged on one allele each, and Vy3 rearranged
on three alleles. Involvement of IV-y 1, IV-y5, 'Vy6, IVy7,
and IVyA was not detected.
Usage of V-y genes in CD3+ T-ALL. The Vy gene usage in
CD3+T-ALL is summarized in Table I and Fig. 4. 12 patients
were examined and these contained a total of 25 rearrange-
ments. In contrast to the findings in CD3- T-ALL, VyI genes
distal to Jy were rearranged in the majority of CD3+ T-ALL.
Amonga total of 25 rearrangements, Vy2 was most frequently
used; eight alleles showed rearrangements of Vy2. Vy3 and
V~y5 were also frequently used; 3 and 5 alleles had rearrange-
ments to V'y3 and Vy5, respectively. Vy4 and TVy7 rear-
ranged on a single allele, respectively, and Vy8 showed rear-
Table L Surface Antigen Expression and Vy Gene Usage in 24
Patients with T Cell Acute Lymphoblastic Leukemia
Surface markers*
Patient CD3 CD4 CD8 CD2 CD7 Vy gene rearranged to Jy
1 - - - - + V-y8,VyI1
2 - - - + + Vy8, Vy9
3 - - - + ND Vy8, Vy9
4 - - + + ND Vy8, Vy9
5 - - + + ND Vy3, Vy8
6 - + - + ND Vy8,Vyll
7 - + + + ND Vy3, Vy8
8 - + 30 20 ND Vy8, Vy9
9 - + + + ND Vy2,Vy4
10 - + 42 + ND Vy3,Vy0O
11 - + + + ND V710,V'11I*
12 - ND ND + + Vy8, Vy9
13 + + - - + Vy2, Vy11
14 + - 20 + ND Vy4, 4IVy7, Vy9*
15 + 40 40 + ND Vy3, Vy8
16 + 19 - + ND V72, Vy8
17 + 10 + + ND V75,Vy5
18 + 29 + + ND Vy3,Vy5
19 + + + + ND Vy2, Vy8
20 + - - + + Vy2,VylO
21 + 27 - - ND Vy3,Vy8
22 + 42 45 + ND Vy2,Vy5
23 + - - + ND V72,Vy5
24 + + - + ND Vy2,Vy2
* A minus sign denotes <10% positive cells and a plus sign >50%
positive cells; numbers are specific percentages of positive cells.
t Rearrangements to Jy 1. 1, Jy 1.2, or Jy2. 1.
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Table I. Phenotype and V'y Gene Usage in 36 Patients with B-Precursor Acute Lymphoblastic Leukemia
Germlinet Germlinet
Vy gene rearranged
Patient Phenotype* y 1 y2 V7 gene rearranged to J'y Patient Phenotype y 1 'y2 to JY
25 III + + Vy4 43 IV + + Vy3
26 III + + VY9 44 IV + + VY9
27 III + + IV'y7 45 III - + Vy5, IVy7
28 III + + V'y4 46 III - + V-y4, Vy9
29 III + + V-y2 47 III - + Vy9, Vy91
30 III + + Vy4 48 III - - Vy2, Vy2
31 III + + V'5 49 III - + Vy4, Vy9
32 III + + Vy5 50 III - + Vy2, V-yI§11
33 III + + Vy9 51 III - + IVy7, Vy9
34 III + + V-y9 52 III - + Vy2, Vy3
35 III + + Vy9 53 III - + IVy7, Vyl l
36 III + + Vy3 54 III - + Vy2, IVy7
37 III + + Vy9 55 III - + Vy2, IV'y7
38 IV + + Vy9 56 III - + VYIlI, VyIN
39 IV + + Vy8 57 III - + Vy2, Vy5
40 IV + + Vy4 58 III - - V-y5, Vy8
41 IV + + Vy9 59 III - + V'y3, Vy4, Vy9
42 IV + + Vy8 60 IV - + Vy2, IV-y7
* III: Ia+, CDl9+, and CD10+, IV: Ia', CD19+, CD10+, and CD20+. $ Results after Bamr HI digestion and hybridization with the Jy probe. +,
retention of germline bands; -, deletion of germline bands. § Rearrangements to Jy 1.1, Jy 1.2, or J-y2. 1. 1" Rearrangements to one of the VYI
family.
rangements on four alleles. V-y9 (VyII), Vy 10 (VyIII), and
V'y 11 (VyIV) were used on only one allele each.
Usage of Vy genes in B-precursor ALL. The usage of indi-
vidual Vy genes in B-precursor ALL is shown in Table II and
Fig. 5. 57 patients with B-precursor ALL were examined of
which 36 showed rearrangement of the TCRy gene. In these
36 patients, a total of 53 rearranged genes were observed. Vy2
and V'y9 were rearranged on a total of 9 and 14 alleles, respec-
tively. Involvement of Vy3, Vy4, Vy5, and Vy8 were ob-
served on four, seven, five, and three alleles, respectively. Re-
arrangements of IVy7 were also frequently observed; seven
alleles showed involvement of IVy7. The usage of Vy 1
(VyIV) was observed on two alleles. Rearrangements of Vy 10
(V~yIII) and pseudogenes other than IVy7 were not observed.
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Figure 4. Usage of Vy genes in 24 patients with T-ALL. Columns in-
dicate the particular Vy gene rearranged in 12 CD3- T-ALL (i) and
12 CD33 T-ALL patients (m).
Thus, no notable selectivity of Vy gene usage was observed in
B-precursor ALL. However, when these patients were subdi-
vided into two subgroups; 20 patients with single allelic rear-
rangements and 16 patients with biallelic rearrangements,
most Vy2 and 'Vy7 rearrangements were observed in pa-
tients with biallelic rearrangements.
Deletion pattern of Vy genes. Eco RI digests probed with
V7yI afford the opportunity to observe all of the VyI genes on
the same blot. This was demonstrated above (Fig. 2 B). In
addition to rearrangements, the complexity of the pattern fa-
cilitates detection of deletions that occur during rearrange-
ment. To analyze the deletion pattern of V7 genes, we exam-
ined the Eco RI digests that had been hybridized with the VyI
and VyII probes in 12 patients with T-ALL. BamHI and Hind
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Figure 5. Usage of Vy genes in 36 patients with B-precursor ALL.
Figure indicates which Vy gene rearranged in 20 patients with single
allelic rearrangements (X) and 16 patients with bi-allelic rearrange-
ments (n).
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Figure 6. Representative deletion patterns of VyI genes using Eco
RI. The patient numbers are noted above each lane. Lane Gand G'
show the germline controls cut with Eco RI. The specific Vy gene
and the size (in kilobases) corresponding to each germline band are
indicated by bars between blots. *Rearranged Vy genes.
III digests hybridized with the V-yII and VyIII probes were also
examined. As illustrated in Fig. 6 and summarized in Table
III, most patients showed deletion of Vy genes intervening
between the rearranged Vy genes and the 3'-most terminus.
These findings support the hypothesis that loop deletion (13,
14) is the primary mechanism for Vy gene rearrangement. As
described earlier (Tables I and II) Pt. 24 was found to be rear-
ranged to Vy2 on both alleles, and Fig. 6 shows that Pt. 24 has
deleted all the V region genes intervening between V72 and
the constant region. Pt. 13 was found to be rearranged to V-y2
and Vy 11, and therefore an apparent germline pattern is ob-
served with this patient. This is solely due to the allele that
rearranged to Vy 1 1. Pt. 9 was shown to rearrange to Vy2 and
Vy4, and Fig. 6 shows that all genes located 5' to Vy4 are in
germline whereas those genes located between V-y4 and the
constant region have been deleted. A similar situation oc-
curred with Pt. 17. Pt. 1 with rearrangements to V-8 and
V~y 11 showed retention of all VyI, VyII, and VyIII genes, and
no germline V'yIV (Vy 1 1) genes identified by the VyIII probe
and Eco RI digestion.
Interesting hybridization patterns of the VyI probe were
observed in three patients (Pts. 10, 19, and 20) with rearrange-
ments involving Vy3 and Vy10, Vy2 and Vy8, and Vy2 and
V710, respectively. In these patients, 7.0-kb bands corre-
sponding to Vy2 and Vy3 and 2.4-kb bands corresponding to
5'Vy4 were lost with the retention of 9.4-kb bands corre-
sponding to IVy5 and IV'y6. Because the intensities of the
9.4-kb bands increased in spite of single allelic deletions of
'Vy5 and IVy6 caused by rearrangements to Vy2 or V'y3, it
is possible that an Eco RI restriction site between Vy3 and
Vy4 may be polymorphic and this polymorphic Eco RI frag-
ment containing Vy2, Vy3, and 5Vy4 may be overlaid on the
normal 9.4-kb band. This possibility is supported by the find-
ings of increased intensities of the 9.4-kb bands compared with
the 7.0-kb bands in germline DNA(Fig. 6, lane G'), and by the
lack of aberrant rearranged bands when samples cut with Hind
III or BamHI were probed.
Discussion
Acute lymphoblastic leukemia results from the clonal expan-
sion of cells arrested at different stages of lymphoid ontogeny
(22, 23). These leukemic cells provide models for analyzing the
molecular events that occur during lymphocyte development
(10, 11, 15, 24-26). In this study, we have analyzed the usage
of Vy genes in patients with T-ALL and B-precursor ALL.
Based on the expression of the CD3 antigen, the patients with
T-ALL were divided into two subgroups: CD3- T-ALL cells
presumably representing T lineage cells arrested early in on-
togeny; CD3+ T-ALL cells presumably derived from a more
mature stage of T cell ontogeny. In CD3- T-ALL, rearrange-
ments frequently involved Vy8 and Vy9, which are located
proximal to Jy, and rearrangements of Vy genes located distal
Table III. Patterns of Vy Gene Deletions in 12 Patients with T Cell Acute Lymphoblastic Leukemia
V-yI V-I* V-yIII,
Patient 'V'y I 5V-y2 Vy2, Vy3 5V-y4 V'y4 I'V-y5, *V-y6 V-y5, *V-y7 V-y8 V-y9 Vy 10 Usage of V-y genes
1 + + + + + + + + + + Vy8,Vy1
8 + + + + + + + + R/D - Vy8, Vy9
9 + + + + - - - - - - Vy2,V-y4
10 + + - - + + + + + R/- Vy3,V-ylO
13 + + + + + + + + + + Vy2, VyI 1
15 + + + + + + + - - - Vy3, V-y8
17 + + + + + - - - - - Vy5, Vy5
19 + + _ _ + + + - - - V'y2, V-y8
20 + + - - + + + + + R/- Vy2,VylIO
22 + + + + + - - - - - Vy2, Vy5
23 + + + + + - - - - - Vy2,Vy5
24 + + - - - - - - - - V'y2,Vy2
+, germline, -, deleted, and R, rearranged. * Results after Eco RI digestion. Results after Eco RI and Hind III digestion. § Results after
Hind III digestion.
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to Jy were less frequently observed. In contrast to the findings
in CD3- T-ALL, leukemic cells from CD3+T-ALL frequently
showed rearrangement of Vy2, which is the most upstream
functional Vy gene detected so far and in these cells, those V'y
genes located distal to Jy (Vy2, Vy3, Vy4, and Vy5) were
rearranged on the majority of alleles. In contrast to a recent
publication (27), we were unable to detect a bias for or against
usage of specific Jy loci, even when cells displayed a decided
bias for Vy usage. This selectivity of Vy gene usage is similar
to that observed in Ig heavy chain gene rearrangements; VH
genes proximal to JH are preferentially used in murine imma-
ture B lineage cells and during further differentiation, expres-
sion of VHgenes proximal to JH is replaced by expression of VH
genes located more 5' (distal) to JH (28, 29).
Others have observed that the proportion of rearrange-
ments involving Jy genes distal to Cy was greater in immature
T cells than mature cells (19). Wehave demonstrated similar
findings for the TCR-a gene; immature T lineage cells prefer-
entially used Ja genes located proximal to Va genes and this
was in sharp contrast to results using mature T lineage cells
(1 1, 30). From work presented here, it appears that V'y genes
proximal to Jy may initially rearrange to Jy genes located
distal to the C'y region in the more immature T cells and
during further differentiation the cells may successively rear-
range using more 5' Vy genes and 3' Jy genes with concomi-
tant deletion of the preexisting VJy complex. It is also possible
that 5' Vy genes may undergo secondary rearrangements re-
sulting in Vy gene replacement without Jy gene replacement
in an analogous manner to that of the Ig heavy chain gene (31,
32). Because our conclusions are drawn from examination of
leukemic cells, the possibility exists that the CD3- leukemic T
cell does not represent the normal precursor for the CD3' T
cell but are rather dead-end cells. Using the Vy probes, dele-
tions of Vy genes located 3' to recombined Vy genes were
observed in all 12 patients analyzed. These findings suggest
that loop deletion is the major mechanism for TCR--y gene
rearrangement and for TCR-a and (3 genes (13, 14).
Leukemic cells from B-precursor ALL showed no notable
preference of Vy gene usage. When patients were subdivided
based on single or biallelic rearrangements, most rearrange-
ments to V72 were observed in cells with rearrangements on
both alleles and are presumably more differentiated with re-
spect to TCR-'y gene rearrangement (1 1). Leukemic cells with
rearrangements on single alleles rarely demonstrated rear-
rangement of Vy2 and rearrangements of Vy9 were the most
frequent. However, unlike the case with T-ALL, definition of
the stage of development by V region selection in B-precursor
ALL does not coincide with definition of developmental stage
using cell surface markers. It seems probable, therefore, that
rearrangement of the TCR-y gene in B-precursor ALL does
not follow the maturational hierarchy outlined above for
TCR-y gene rearrangement in T-ALL.
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